Antimicrobial Resistance Pattern of Uropathogens Isolated from Rafha Central Hospital, Rafha, Kingdom of Saudi Arabia

Antimicrobial resistance (AMR) is the capability of a microorganism to neutralize the harmful effects of a drug. AMR is an increasing health problem worldwide. UTIs are among the most common infection in human accounting for 150 million cases globally. E. coli is the most common pathogen responsible for these infections. The uropathogens are getting resistant to commonly used antibiotics. The current study was designed to evaluate the antibiotic resistance pattern of the uropathogens against commonly administered antibiotics in patients visiting Rafha central Hospital, Rafha city, Saudi Arabia. The study was done retrospectively and the data was collected from the hospital lab from January 2016 to December 2017. During that period, 623 positive cases were observed. E. coli was the most prevalent UTI pathogen. Resistance against 27 commonly used antibiotics was studied. Among β-Lactam antibiotics, increasing resistance was observed except for Augmentin. The imipenem was relatively more effective. Among non-2 Lactam group, least resistance was seen against Vancomycin and Amikacin. Overall increase in antibiotic resistance was observed in the current study with some exceptions. It is therefore recommended that the routine urine cultures must be done and the resistance pattern in the region must regularly be monitored.

[1]  J. Mecsas,et al.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense , 2016, Microbiology and Molecular Reviews.

[2]  W. Hryniewicz,et al.  Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[3]  A. Walker,et al.  Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998–2014 , 2016, Thorax.

[4]  N. Pal,et al.  Antibiotic resistance pattern of Enterococci isolates from nosocomial infections in a tertiary care hospital in Eastern India , 2015, Journal of natural science, biology, and medicine.

[5]  Awad Al-omari,et al.  Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA) , 2015, Journal of chemotherapy.

[6]  A. Torres,et al.  Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. , 2015, The Journal of infection.

[7]  A. Dashti,et al.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolates in the Gulf Cooperation Council States: Dominance of OXA-23-Type Producers , 2015, Journal of Clinical Microbiology.

[8]  S. Arabia,et al.  Prevalence and risk factors of community-acquired urinary tract infections due to ESBL-producing Gram negative bacteria in an Armed Forces Hospital in Sothern Saudi Arabia , 2015 .

[9]  A. Cheng,et al.  Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control study , 2014, BMC Infectious Diseases.

[10]  Kamaljit Singh,et al.  Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department , 2013, Emergency medicine international.

[11]  I. Sharma,et al.  Prevalence of community acquired urinary tract infections in Silchar Medical College, Assam, India and its antimicrobial susceptibility profile. , 2012, Indian journal of medical sciences.

[12]  E. Larson,et al.  Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Richard Colgan,et al.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  K. Mertens,et al.  Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. , 2011, The Lancet. Infectious diseases.

[15]  A. Candevir,et al.  Antibiotic resistance in community-acquired urinary tract infections: prevalence and risk factors. , 2010, Medical science monitor : international medical journal of experimental and clinical research.

[16]  S. Farajnia,et al.  Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[17]  D. Livermore,et al.  Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. , 2008, The Journal of antimicrobial chemotherapy.

[18]  C. Vincent,et al.  Endemic and Epidemic Lineages of Escherichia coli that Cause Urinary Tract Infections , 2008, Emerging infectious diseases.

[19]  K. Laupland,et al.  Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. , 2008, The Journal of infectious diseases.

[20]  J. Maselli,et al.  National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. , 2008, Archives of internal medicine.

[21]  E. Akortha,et al.  Incidence and antibiotic susceptibility pattern of Staphylococcus aureus amongst patients with urinary tract infection (UTI) in UBTH Benin City, Nigeria , 2008 .

[22]  Roberta B Carey,et al.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.

[23]  Mohammed Shahid,et al.  Annals of Clinical Microbiology and Antimicrobials Open Access Etiology and Antibiotic Resistance Patterns of Community-acquired Urinary Tract Infections in J N M C Hospital Aligarh, India , 2022 .

[24]  Roberta B Carey,et al.  Methicillin-resistant S. aureus infections among patients in the emergency department. , 2006, The New England journal of medicine.

[25]  O. Ergönül,et al.  Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. , 2005, The Journal of antimicrobial chemotherapy.

[26]  J. Versalovic,et al.  Three-year surveillance of community-acquired Staphylococcus aureus infections in children. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  L. Davis,et al.  Increasing antimicrobial resistance patterns of community and nosocomial uropathogens , 2005 .

[28]  R. Lynfield,et al.  Methicillin-resistant Staphylococcus aureus disease in three communities. , 2005, The New England journal of medicine.

[29]  Stephen F Eckel,et al.  Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  W. Stamm,et al.  Urinary tract infections: disease panorama and challenges. , 2001, The Journal of infectious diseases.

[31]  David N. Williams.  Urinary tract infection. , 1996, Postgraduate medicine.

[32]  D. Williams.  Urinary tract infection: emerging insights into appropriate management. , 1996, Postgraduate medicine.

[33]  A. Bergman.  Urinary tract infections in women , 1991, Current opinion in obstetrics & gynecology.